The role of microbiota in the management of genitourinary syndrome of menopause

References

• Ribeiro AE, Monteiro NS, Moraes AVD, et al. Can the use of probiotics in association with isoflavone improve the symptoms of genitourinary syndrome of menopause? Results from a randomized controlled trial. Menopause. 2018;26(6):643–652. doi: 10.1097/GME.0000000000001279.
   PubMed Web of Science ®Google Scholar
• Stabile G, Ricci G, Scalia MS, et al. Induced dryness stress on human vaginal epithelium: the efficacy of a new vaginal gel. Gels. 2021;7(4):157. doi: 10.3390/gels7040157.
   PubMed Web of Science ®Google Scholar
• Van Gerwen OT, Smith SE, Muzny CA. Bacterial vaginosis in postmenopausal women. Curr Infect Dis Rep. 2023;25(1):7–15. doi: 10.1007/s11908-022-00794-1.
   Web of Science ®Google Scholar
• Chopra C, Bhushan I, Mehta M, et al. Vaginal microbiome: considerations for reproductive health. Future Microbiol. 2022;17(18):1501–1513. doi: 10.2217/fmb-2022-0112.
   PubMed Web of Science ®Google Scholar
• Petricevic L, Domig KJ, Nierscher FJ, et al. Differences in the vaginal lactobacilli of postmenopausal women and influence of rectal lactobacilli. Climacteric. 2013;16(3):356–361. doi: 10.3109/13697137.2012.725788.
   PubMed Web of Science ®Google Scholar
• Mueck AO, Ruan X, Prasauskas V, et al. Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review. Climacteric. 2018;21(2):140–147. doi: 10.1080/13697137.2017.1421923.
   PubMed Web of Science ®Google Scholar
• Witkin SS, Linhares IM, Giraldo P, et al. An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin Infect Dis. 2007;44(4):554–557. doi: 10.1086/511045.
   PubMed Web of Science ®Google Scholar
• Gajer P, Brotman RM, Bai G, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132ra52. doi: 10.1126/scitranslmed.3003605.
   PubMed Web of Science ®Google Scholar
• Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85(1):87–94. doi: 10.4065/mcp.2009.0413.
   PubMed Web of Science ®Google Scholar
• McGroarty JA. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol. 1993;6(4):251–264. doi: 10.1111/j.1574-695X.1993.tb00337.x.
   PubMedGoogle Scholar
• Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis. 1990;12(5):856–872. doi: 10.1093/clinids/12.5.856.
   PubMedGoogle Scholar
• Kanne B, Jenny J. Local administration of low-dosed estriol and viable Lactobacillus acidophilus in the post-menopausal period. GynakolRundsch. 1991;31:7–13. [German]
   Google Scholar
• Brotman RM, Shardell MD, Gajer P, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21(5):450–458. doi: 10.1097/GME.0b013e3182a4690b.
   PubMed Web of Science ®Google Scholar
• Szymański JK, Słabuszewska-Jóźwiak A, Jakiel G. Vaginal aging—what we know and what we do not know. IJERPH. 2021;18(9):4935. doi: 10.3390/ijerph18094935.
   Web of Science ®Google Scholar
• Gandhi K, Manales NJ, Garza J, et al. Lactobacilli and cytokine modifications during menopause and their relation to vulvar and vulvovaginal disorders. J Menopausal Med. 2022;28(2):52–59. doi: 10.6118/jmm.22001.
   PubMedGoogle Scholar
• Yoshikata R, Yamaguchi M, Mase Y, et al. Age-related changes, influencing factors, and crosstalk between vaginal and gut microbiota: a cross-sectional comparative study of pre- and postmenopausal women. J Womens Health (Larchmt). 2022;31(12):1763–1772. doi: 10.1089/jwh.2022.0114.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233–238. doi: 10.1016/j.maturitas.2010.08.001.
   PubMed Web of Science ®Google Scholar
• De Seta F, Stabile G, Antoci G, et al. Provoked vestibulodynia and topical treatment: a new option. Healthcare. 2022;10(5):830. doi: 10.3390/healthcare10050830.
   Web of Science ®Google Scholar
• Stabile G, Mordeglia D, Romano F, et al. Postcoital vaginal perforation and evisceration in women with no prior pelvic surgery: laparoscopic management and systematic review of the literature. IJERPH. 2021;18(18):9746. doi: 10.3390/ijerph18189746.
   Web of Science ®Google Scholar
• Cancelo-Hidalgo MJ, Coello LB. 2017. Genitourinary syndrome of the menopause: vaginal health and microbiota. In: A. Cano, editors. Menopause. Cham: Springer.
   Google Scholar
• Nappi RE, Panay N, Bruyniks N, et al. The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. Climacteric. 2015;18(2):233–240. doi: 10.3109/13697137.2014.975199.
   PubMed Web of Science ®Google Scholar
• Naumova I, Castelo-Branco C. Current treatment options for postmenopausal vaginal atrophy. Int J Womens Health. 2018;10:387–395. doi: 10.2147/IJWH.S158913.
   PubMed Web of Science ®Google Scholar
• Palacios S, Castelo-Branco C, Currie H, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas. 2015;82(3):308–313. doi: 10.1016/j.maturitas.2015.07.020.
   PubMed Web of Science ®Google Scholar
• Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric. 2016;19(2):151–161. doi: 10.3109/13697137.2015.1124259.
   PubMed Web of Science ®Google Scholar
• Juraskova I, Jarvis S, Mok K, et al. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med. 2013;10(10):2549–2558. doi: 10.1111/jsm.12156.
   PubMed Web of Science ®Google Scholar
• Łaniewski P, Owen KA, Khnanisho M, et al. Clinical and personal lubricants impact the growth of vaginal lactobacillus species and colonization of vaginal epithelial cells: an in vitro study. Sex Transm Dis. 2021;48(1):63–70. doi: 10.1097/OLQ.0000000000001272.
   PubMed Web of Science ®Google Scholar
• Hung KJ, Hudson PL, Bergerat A, et al. Effect of commercial vaginal products on the growth of uropathogenic and commensal vaginal bacteria. Sci Rep. 2020;10(1):7625. doi: 10.1038/s41598-020-63652-x.
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–522. doi: 10.3109/13697137.2010.522875.
   PubMed Web of Science ®Google Scholar
• Rahn DD, Carberry C, Sanses TV, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol. 2014;124(6):1147–1156. doi: 10.1097/AOG.0000000000000526.
   PubMed Web of Science ®Google Scholar
• Mendoza N, Abad P, Baró F, et al. Spanish Menopause Society position statement: use of tibolone in postmenopausal women. Menopause. 2013;20(7):754–760. doi: 10.1097/GME.0b013e31827b18c5.
   PubMed Web of Science ®Google Scholar
• Pickar JH. Emerging therapies for postmenopausal vaginal atrophy. Maturitas. 2013;75(1):3–6. doi: 10.1016/j.maturitas.2013.01.020.
   PubMed Web of Science ®Google Scholar
• Goldstein I. Recognizing and treating urogenital atrophy in postmenopausal women. J Womens Health (Larchmt). 2010;19(3):425–432. doi: 10.1089/jwh.2009.1384.
   PubMed Web of Science ®Google Scholar
• Simon JA. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen. J Womens Health (Larchmt). 2011;20(10):1453–1465. doi: 10.1089/jwh.2010.2151.
   PubMed Web of Science ®Google Scholar
• Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–711. doi: 10.1016/j.ajog.2016.07.045.
   PubMed Web of Science ®Google Scholar
• Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2006;(4):CD001500.
   PubMedGoogle Scholar
• Pickar JH, Amadio JM, Bernick BA, et al. Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule. Climacteric. 2016;19(2):181–187. doi: 10.3109/13697137.2015.1136926.
   PubMed Web of Science ®Google Scholar
• Mitchell CM, Reed SD, Diem S, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvo vaginal symptoms: a randomized clinical trial. JAMA Intern Med. 2018;178(5):681–690. doi: 10.1001/jamainternmed.2018.0116.
   PubMed Web of Science ®Google Scholar
• Wurz GT, Soe LH, DeGregorio MW. Ospemifene, vulvovaginal atrophy, and breast cancer. Maturitas. 2013;74(3):220–225. doi: 10.1016/j.maturitas.2012.12.002.
   PubMed Web of Science ®Google Scholar
• Panjari M, Davis SR. Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas. 2011;70(1):22–25. doi: 10.1016/j.maturitas.2011.06.005.
   PubMed Web of Science ®Google Scholar
• Stabile G, Scalia MS, Carlucci S, et al. Ladylift® non-ablative laser technology for the treatment of menopausal vestibulodynia and genitourinary syndrome. Prz Menopauzalny. 2022;21(4):253–258. doi: 10.5114/pm.2022.124015.
   PubMedGoogle Scholar
• Salvatore S, Leone Roberti Maggiore U, Athanasiou S, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015;22(8):845–849. doi: 10.1097/GME.0000000000000401.
   PubMed Web of Science ®Google Scholar
• Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30(1):429–436. doi: 10.1007/s10103-014-1677-2.
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Pitsouni E, Antonopoulou S, et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric. 2016;19(5):512–518. doi: 10.1080/13697137.2016.1212006.
   PubMed Web of Science ®Google Scholar
• Jaisamrarn U, Triratanachat S, Chaikittisilpa S, et al. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric. 2013;16(3):347–355. doi: 10.3109/13697137.2013.769097.
   PubMed Web of Science ®Google Scholar
• Henry LP, Bruijning M, Forsberg SKG, et al. The microbiome extends host evolutionary potential. Nat Commun. 2021;12(1):5141. doi: 10.1038/s41467-021-25315-x.
   PubMed Web of Science ®Google Scholar
• Pines A. Microbiotica in women. Climacteric. 2015;18(5):666–668. doi: 10.3109/13697137.2015.1017337.
   PubMed Web of Science ®Google Scholar
• Mitchell CM, Srinivasan S, Zhan X, et al. Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. Menopause. 2017;24(10):1160–1166. doi: 10.1097/GME.0000000000000904.
   PubMed Web of Science ®Google Scholar
• Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014;289(3):479–489. doi: 10.1007/s00404-013-3064-9.
   PubMed Web of Science ®Google Scholar
• Dobrokhotova YE, Shadrova PA, Komagorov VI. Vaginal microbiota during the menopausal transition: the role of lactobacilli. Gynecol. 2021;23(3):214–221. doi: 10.26442/20795696.2021.3.200905.
   Google Scholar
• Marino JM. Genitourinary syndrome of menopause. J Midwifery Womens Health. 2021;66(6):729–739. doi: 10.1111/jmwh.13277.
   PubMed Web of Science ®Google Scholar
• Gliniewicz K, Schneider GM, Ridenhour BJ, et al. Comparison of the vaginal microbiomes of premenopausal and postmenopausal women. Front Microbiol. 2019;10:193. doi: 10.3389/fmicb.2019.00193.
   PubMed Web of Science ®Google Scholar
• Mitchell CM, Srinivasan S, Plantinga A, et al. Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem. Menopause. 2018;25(5):500–507. doi: 10.1097/GME.0000000000001037.
   PubMed Web of Science ®Google Scholar
• Kim S, Seo H, Rahim MA, et al. Changes in the microbiome of vaginal fluid after menopause in Korean women. J Microbiol Biotechnol. 2021;31(11):1490–1500. doi: 10.4014/jmb.2106.06022.
   PubMed Web of Science ®Google Scholar
• Lim EY, Lee SY, Shin HS, et al. The effect of Lactobacillus acidophilus YT1 (MENOLACTO) on improving menopausal symptoms: a randomized, double-blinded, placebo-controlled clinical trial. JCM. 2020;9(7):2173. doi: 10.3390/jcm9072173.
   Google Scholar
• Petricevic L, Unger FM, Viernstein H, et al. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):54–57. doi: 10.1016/j.ejogrb.2008.06.003.
   PubMed Web of Science ®Google Scholar
• Sawada D, Sugawara T, Hirota T, et al. Effects of Lactobacillus gasseri CP2305 on mild menopausal symptoms in Middle-Aged women. Nutrients. 2022;14(9):1695. doi: 10.3390/nu14091695.
   PubMed Web of Science ®Google Scholar
• Yoshikata R, Yamaguchi M, Mase Y, et al. Evaluation of the efficacy of lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre- and postmenopausal women: a pilot randomized controlled trial. PLoS One. 2022;17(12):e0270242. doi: 10.1371/journal.pone.0270242.
   PubMed Web of Science ®Google Scholar
• Bisanz JE, Seney S, McMillan A, et al. A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women. PLoS One. 2014;9(8):e10451. doi: 10.1371/journal.pone.0104511.
   Web of Science ®Google Scholar
• Hesham H, Mitchell AJ, Bergerat A, et al. Impact of vaginaldouching products on vaginal lactobacillus, Escherichia coli and epithelial immune responses. Sci Rep. 2021;11(1):23069. doi: 10.1038/s41598-021-02426-5.
   PubMed Web of Science ®Google Scholar
• Mitchell CM, Srinivasan S, Ma N, et al. Bacterial communities associated with abnormal nugent score in postmenopausal versus premenopausal women. J Infect Dis. 2021;223(12):2048–2052. doi: 10.1093/infdis/jiaa675.
   PubMed Web of Science ®Google Scholar
• Mitchell CM, Ma N, Mitchell AJ, et al. Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation. Am J Obstet Gynecol. 2021;225(2):159.e1. doi: 10.1016/j.ajog.2021.02.034.
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Hua X, Wu MC, et al. Impact of topical interventions on the vaginal microbiota and metabolome in postmenopausal women: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2022;5(3):e225032. doi: 10.1001/jamanetworkopen.2022.5032.
   PubMed Web of Science ®Google Scholar